Dietmar Krex

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

Michael Weller, Jörg Felsberg, Christian Hartmann et al. · Journal of Clinical Oncology · 2009 · 611 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 576 citations · Full text

Medicine, Oncology, Pharmacology +16

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

Medicine, Immunology, Oncology +17

5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with <i>IDH1</i> Mutations

Seung‐Gi Jin, Yong Jiang, Runxiang Qiu et al. · Cancer Research · 2011 · 451 citations

Medicine, Molecular Biology, Oncology +13

A vaccine targeting mutant IDH1 in newly diagnosed glioma

Michael Platten, Lukas Bunse, Antje Wick et al. · Nature · 2021 · 425 citations · Full text

Medicine, Immunology, Oncology +17